Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy

Evidence for research over the past decade shows that epigenetic regulation mechanisms run through the development and prognosis of tumors. Therefore, small molecular compounds targeting epigenetic regulation have become a research hotspot in the development of cancer therapeutic drugs. According to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Donglu, Qiu, Ye, Jiao, Yunshuang, Qiu, Zhidong, Liu, Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686570/
https://www.ncbi.nlm.nih.gov/pubmed/33262941
http://dx.doi.org/10.3389/fonc.2020.560487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686570/
https://www.ncbi.nlm.nih.gov/pubmed/33262941
http://dx.doi.org/10.3389/fonc.2020.560487

Ejemplares similares